Author:
Cooper Nicola,Teixeira Mauro M,Warneck Julie,Miotla Jadwiga M,Wills Ruth E,Macari David M T,Gristwood Robert W,Hellewell Paul G
Reference40 articles.
1. Effect of PDE4 inhibitors on zymosan-induced IL-8 release form human neutrophils: Synergism with prostanoids and salbutamol;AU;Br. J. Pharmacol.,1998
2. Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site;BARNETTE;J. Pharmacol. Exp. Ther.,1995a
3. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity;BARNETTE;J. Pharmacol. Exp. Ther.,1995b
4. Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding;BARNETTE;Biochem. Pharmacol.,1996
5. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions;BARNETTE;J. Pharmacol. Exp. Ther.,1998
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献